Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, GenDx Ink Reseller Agreement for Ion Torrent in HLA Typing

NEW YORK (GenomeWeb) – GenDx announced today that it has signed a global reseller agreement, giving it the rights to offer Thermo Fisher Scientific's Ion Torrent next-generation sequencing systems and consumables as part of a human leukocyte antigen (HLA) typing workflow used in transplant diagnostics.

Under the terms of the agreement, Netherlands-based GenDx and its distributors can provide the Ion PGM, S5, and Chef systems to customers alongside GenDx's HLA-NGSgo reagents and NGSengine software.

In recent years, NGS-based HLA typing has started to gain momentum, with Illumina and CareDx making deals in the space. GenDx has acquired CE-IVD marking for its HLA typing workflow for the Illumina MiSeq, NGSengine software product, and for its Sanger sequencing-based workflow. The firm said in a statement that it has begun the process of getting the CE mark for NGSgo on the Ion Torrent platform.

"We have evaluated the HLA typing results with the NGSgo full workflow strategies on multiple NGS platforms," GenDx CEO Wietse Mulder said in a statement. "The Ion PGM and Ion S5 systems provide reliable typing results that are of high resolution and phasing comparable to other NGS platforms on the market."

Financial and other terms of the agreement were not disclosed.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.